Hopkins Sean P, Frost Megan C
Department of Biomedical Engineering, Michigan Technological University, 1400 Townsend Dr., Houghton, MI 49931, USA.
Bioengineering (Basel). 2020 Jan 10;7(1):9. doi: 10.3390/bioengineering7010009.
Synthetic nitric oxide (NO)-donating materials have been shown to have many beneficial effects when incorporated into biomedical materials. When released in the correct dosage, NO has been shown to increase the biocompatibility of blood and tissue contacting materials, but materials are often limited in the amount of NO that can be administered over a period of time. To address this, hyperbranched polyamidoamine (HPAMAM) was modified with the S-nitrosothiol, S-nitroso--acetyl-D-penicillamine, and nitrosated to form a controlled, high-capacity NO-donating compound (SNAP-HPAMAM). This compound has the potential of modifying polymers to release NO over long periods of time by being blended into a variety of base polymers. Nitric oxide release was triggered by photoinitiation and through passive ion-mediated release seen under physiological conditions. A material that delivers the beneficial dose of NO over a long period of time would be able to greatly increase the biocompatibility of long-term implantable devices. Structural analysis of a generation 2 HPAMAM molecule was done through Fourier transform infrared spectroscopy (FTIR), H nuclear magnetic resonance spectroscopy (NMR), and matrix assisted laser desorption ionization, time of flight (MALDI-TOF) mass spectrometry. The NO capacity of the finalized generation 2 SNAP-HPAMAM compound was approximately 1.90 ± 0.116 µmol NO/mg. Quantification of the functional groups in the compound proved that an average of 6.40 ± 0.309 reactive primary amine sites were present compared to the 8 reactive sites on a perfectly synthesized generation 2 dendrimer. There is a substantial advantage of using the hyper-branched HPAMAM over purified dendrimers in terms of reduced labor and expense while still providing a high-capacity NO donor that can be blended into different polymer matrices.
已证明,将合成一氧化氮(NO)供体材料掺入生物医学材料中具有许多有益效果。当以正确剂量释放时,NO已被证明可提高与血液和组织接触的材料的生物相容性,但材料在一段时间内可施用的NO量通常受到限制。为了解决这个问题,用S-亚硝基硫醇、S-亚硝基乙酰-D-青霉胺对超支化聚酰胺胺(HPAMAM)进行修饰并亚硝化,以形成一种可控的、高容量的NO供体化合物(SNAP-HPAMAM)。通过与各种基础聚合物共混,该化合物具有修饰聚合物以长时间释放NO的潜力。一氧化氮的释放是由光引发触发的,并通过生理条件下的被动离子介导释放实现。一种能在长时间内递送有益剂量NO的材料将能够大大提高长期可植入装置的生物相容性。通过傅里叶变换红外光谱(FTIR)、氢核磁共振光谱(NMR)和基质辅助激光解吸电离飞行时间(MALDI-TOF)质谱对第2代HPAMAM分子进行了结构分析。最终的第2代SNAP-HPAMAM化合物的NO容量约为1.90±0.116μmol NO/mg。对化合物中官能团的定量分析证明,与完美合成的第2代树枝状大分子上的8个反应位点相比,平均存在6.40±0.309个反应性伯胺位点。与纯化的树枝状大分子相比,使用超支化HPAMAM具有显著优势,即减少了劳动力和费用,同时仍提供了一种可与不同聚合物基质共混的高容量NO供体。